About our Premium Reports
Our Premium Reports are specialized reports that are only available to active users with HealthTech Alpha Pro and HealthTech Alpha Enterprise accounts and are provided at no additional cost.
This is the Executive Summary of the Digital Health in Pharma Research report. Firstly, we explore the boundaries of Pharma Research. Secondly, we explain the current trends in the Pharma Research. In summary, our analysis focuses on private ventures and start-ups. It includes noteworthy partnerships, spotlight ventures, and venture funding. HealthTech Alpha, a Galen Growth proprietary solution, powers this report!
The full report contains the following key highlights:
HealthTech Alpha, Galen Growth’s proprietary on-demand platform, is the data source for this report. HealthTech Alpha contains more than 170 million data points and hence is the leading Digital Health intelligence and analytics platform! Moreover, its coverage exceeds 11,500 Digital Health ventures globally. For more information visit https://www.healthtechalpha.com/
Find the full report on: https://www.galengrowth.com/research
Our Premium Reports are specialized reports that are only available to active users with HealthTech Alpha Pro and HealthTech Alpha Enterprise accounts and are provided at no additional cost.
Galen Growth’s proprietary platform, HealthTech Alpha, provides the data source for this report. Corporate Business Development, Business Intelligence, and Digital Health Partnership teams worldwide prefer HealthTech Alpha, the world’s most-trusted Digital Health data, intel, and insights platform. Visit https://www.healthtechalpha.com to learn more about our data or https://www.galengrowth.com research for our reports.
Founded in 2016 by Digital Health experts, Galen Growth empowers global Fortune 500 companies, institutional investors, and promising Digital Health ventures to fast track their digital health strategy to create significant financial and social values. To find out more, visit https://www.galengrowth.com